[Special Stock] DXVX Hits Upper Limit on News of Accelerated Obesity Treatment Development↑
Biohealthcare specialist company DXVX has hit the upper price limit (the highest daily price limit).
As of 2:42 PM on the 18th, DXVX is trading at 2,195 KRW, up 506 KRW (29.96%) from the previous trading day.
This rise appears to be driven by news accelerating the development of an oral obesity treatment.
Hot Picks Today
In the Same Neighborhood, One Apartment Costs 2 Billion Won, Another 450 Million... What's Happening in Gangnam?
- "Will the Semiconductor Industry Be in Trouble?" Stock Prices Have Fallen, but Investments May Increase [Weekend Money]
- "Had Prepared So Much... Then Suddenly Told Not to Appear" Jomin Notified of Cancellation 90 Minutes Before Broadcast
- "Why Don't They Disclose Salaries?"... Half of Job Seekers Give Up Applying
- "Fighter Jet Lost in Blizzard During Korean War Discovered Off Yangyang After 74 Years"
On the same day, DXVX announced that based on previous research results confirming superiority over control substances in late-stage clinical trials, it is currently optimizing its oral GLP (glucagon-like peptide)-1 obesity drug candidate.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.
